Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.

Oncotarget · 2016 · PMC5295456 · PMID 27517632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although we have used limited number of samples, the difference is statistically highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.